Heart valve disease progression and outcomes study
Part of Digestive system, Heart & circulation clinical trials.
This study is following people with heart valve disease (leaky or narrowed valves) to understand how the disease changes over time and what problems it may cause. It does not test a new treatment, but helps doctors learn more about valve disease progression.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have been diagnosed with a heart valve disease (leaky or narrowed valve) by an ultrasound (echocardiogram).
- Your valve problem is at least moderate or higher in severity (e.g., moderate or severe leak or narrowing).
- You are willing to have your data collected and be followed over time.
- You do not have a serious non-heart disease (like cancer or advanced kidney/lung disease) that would limit your life to less than one year.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at the health of people with heart valve disease over several years, using echocardiograms (ultrasounds of the heart) to see how the condition changes. It may help doctors understand and improve care for people with this condition.
This study follows people with moderate aortic valve disease to learn how their condition changes. It does not test a new treatment but will help doctors better understand the disease.
This study follows adults with leaky or narrowed heart valves who are being considered for a valve procedure. It helps doctors better understand patient outcomes and care decisions for these valve problems.
This trial focuses on people with severe mitral valve narrowing or leaking who still have symptoms even after the best usual medications. It may help find better care and measure health outcomes when surgery is judged too risky or not suitable.
This study looks at people with multiple or mixed heart valve disease (moderate or severe) using echocardiography. It aims to learn more about how these conditions affect patients and help guide future care.
This study enrolls adults in the hospital with certain heart valve problems to track their health over time. It may help doctors better understand how valve disease behaves and what outcomes look like in real life.
Hear when a new Mitral Valve (MV) Regurgitation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.